🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge
Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

uTPI: A utility‐based toxicity probability interval design for phase I/II dose‐finding trials

Statistics in Medicine(2021)10.1002/sim.8922Source: DataRank Database

uTPI: A utility‐based toxicity probability interval design for phase I/II dose‐finding trials is a research paper published in Statistics in Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 24 times.

N/A
0DataRank · unranked

Scored on demand from live citation data

Open Access24 citations
Download PDF
Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring
Enrichment:Funding (4 grants)Impact (FWCI 3.60)OA: greenTopics (34)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)
Findable (1/2)
  • Has DOI
Accessible (1/2)
  • Open Access
Interoperable (0/2)
    Reusable (0/3)

      FAIR checklist signals are shown for context only and do not affect DataRank scoring.

      Run a calibrated FAIR evaluation for this paper →

      We only score data papers we can read in full — never from an abstract alone.

      Authors (4)

      Jiguo CaoORCID,Ying YuanORCID,Ruitao LinORCID,Haolun ShiORCID
      Live enrichment
      PubMed:33650708PMC:PMC13138761OpenAlex:https://openalex.org/W3134342065

      National Institutes of Health

      Grant: P30 CA016672

      National Institutes of Health

      Grant: P50 CA098258

      National Institutes of Health

      Grant: P50 CA221703

      NCI NIH HHS

      Grant: R01 CA261978

      FWCI

      3.60

      Citation Percentile

      0.9%

      Citation Trend

      2021
      2022
      2024
      2025
      2026

      greenLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor
      repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC13138761/
      repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC13138761/
      publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.8922
      publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/sim.8922
      journalhttps://doi.org/10.1002/sim.8922

      Fields of Study

      Statistical Methods in Clinical TrialsOptimal Experimental Design MethodsHealth Systems, Economic Evaluations, Quality of Life

      MeSH Terms

      Antineoplastic AgentsBayes TheoremComputer SimulationDose-Response Relationship, DrugHumansProbabilityResearch DesignModels, StatisticalClinical Trials, Phase I as TopicClinical Trials, Phase II as TopicMaximum Tolerated Dose

      Keywords

      Maximum tolerated doseConfidence intervalClinical trialToxicityParametric statisticsComputer scienceMedicineClinical study designOptimal designInterval (graph theory)StatisticsMathematicsMachine learningInternal medicineUtilityDose FindingPhase I/ii TrialsOptimal Biological DoseDose DesirabilityBayesian Quasi Likelihood